D
Dyne Therapeutics, Inc. DYN
$13.41 $0.141.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 53.79M 62.48M 56.02M 50.18M 48.09M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 397.10M 343.89M 314.47M 271.08M 265.85M
Operating Income -397.10M -343.89M -314.47M -271.08M -265.85M
Income Before Tax -367.13M -317.42M -294.51M -257.60M -257.40M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -367.13 -317.42 -294.51 -257.60 -257.40
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -367.13M -317.42M -294.51M -257.60M -257.40M
EBIT -397.10M -343.89M -314.47M -271.08M -265.85M
EBITDA -395.31M -342.21M -312.84M -269.47M -264.21M
EPS Basic -3.59 -3.35 -3.56 -3.58 -3.97
Normalized Basic EPS -2.25 -2.10 -2.23 -2.24 -2.48
EPS Diluted -3.59 -3.35 -3.56 -3.58 -3.97
Normalized Diluted EPS -2.25 -2.10 -2.23 -2.24 -2.48
Average Basic Shares Outstanding 405.28M 376.42M 335.83M 296.05M 263.38M
Average Diluted Shares Outstanding 405.28M 376.42M 335.83M 296.05M 263.38M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --